AdaptHealth Reports Q2 Earnings Dip, Reaffirms Growth Strategy and Adjusts Full-Year Outlook

AdaptHealth

CONSHOHOCKEN, PAAdaptHealth Corp. (NASDAQ: AHCO) reported a slight revenue decline in its second quarter results but remains confident in its long-term strategy, highlighting operational improvements, enhanced patient services, and a major new national partnership.

For the quarter ended June 30, 2025, AdaptHealth posted net revenue of $800.4 million, down 0.7% from $806 million during the same period last year. Net income attributable to the company fell to $14.7 million, compared to $19.4 million in Q2 2024. Adjusted EBITDA also declined, landing at $155.5 million—a 5.9% drop from the prior year.

Despite the softness in top-line results, the company pointed to several operational wins. Year-to-date cash flow from operations rose to $257.5 million, up from $247 million in the same period last year. Free cash flow reached $73.3 million, slightly down from $77.9 million year-over-year. The company also completed the previously announced divestitures of certain incontinence and infusion assets from its Wellness at Home segment.

READ:  Context Therapeutics Highlights Pipeline Progress, Reports $8.8M Loss in Q2

“AdaptHealth’s momentum continues to build,” said CEO Suzanne Foster. “We delivered another quarter of solid results… We are driving revenue growth, underscored by today’s milestone announcement of a new capitated partnership with a major national healthcare system. We are advancing multiple initiatives to boost operating efficiency, elevate the patient experience, and expand our profit margins.”

The new agreement with a national healthcare system, announced concurrently, positions AdaptHealth as the exclusive provider of home medical equipment to over 10 million members under a capitation model—offering a more stable and scalable revenue stream moving forward.

READ:  Comcast Posts Solid Q2 Gains with Strong Wireless Growth and Theme Park Momentum

In light of second-quarter performance and the impact of the new partnership, AdaptHealth adjusted its full-year 2025 guidance. The company now expects revenue between $3.18 billion and $3.26 billion, slightly tightening its previous range. Adjusted EBITDA is projected between $642 million and $682 million, down from the earlier forecast of $662 million to $702 million. Free cash flow expectations remain unchanged at $170 million to $190 million.

AdaptHealth serves approximately 4.2 million patients across the U.S. and continues to focus on strengthening its financial position while delivering care through scalable, tech-enabled home healthcare solutions.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.